AMAndré Miotto

André Miotto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


André Miotto has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intercostal Cryoanalgesia Versus Thoracic Epidural Analgesia for Postoperative Pain Control After Thoracic Surgery: Study Protocol for a Randomized Clinical Trial

    by André Miotto, Juliana P Franceschini, Maria Luiza de Paula Pereira, Isabella Correia da Rocha, Maria Luiza Campos Ferreira, Suéllen Battaglini Rolando, Ernesto Evangelista Neto, João Aléssio Juliano Perfeito

    Background: Post-thoracic surgery pain remains a major clinical challenge, with substantial impact on pulmonary function, postoperative recovery, and patient quality of life. Thoracic epidural analgesia is widely regarded as the standard of care; however, it is associated with potential complications, including hypotension, urinary retention, and inadequate analgesia in a subset of patients. Intercostal cryoanalgesia, a peripheral nerve block technique that induces temporary axonal degeneration through controlled freezing, has emerged as a potential alternative for prolonged postoperative pain control. Objective: The primary objective of this study is to compare postoperative hospital length of stay between intercostal cryoanalgesia and thoracic epidural analgesia. Secondary objectives include the evaluation of postoperative pain intensity, opioid consumption, adverse effects, postoperative complications, quality of life, quality of recovery, and patient satisfaction. Methods: This is a single-center, prospective, randomized, parallel-group clinical trial comparing intercostal cryoanalgesia with thoracic epidural analgesia for postoperative pain control in patients undergoing thoracic surgery. Fifty adult patients (≥18 y) are randomized 1:1 to either epidural or cryoanalgesia groups. All perioperative and postoperative care is provided by the attending clinical teams according to routine institutional practice, with no influence from the research team beyond randomized allocation. The primary endpoint is postoperative hospital length of stay. Secondary outcomes include pain intensity (visual analog scale), opioid consumption, incidence of adverse effects and complications, quality of life (WHOQOL-BREF), and quality of recovery (QoR-15). Data are collected up to 1 year postoperatively. Results: Approval from the Human Research Ethics Committee was obtained in November 2024, and participant recruitment began in July 2025. Data collection commenced concurrently with participant recruitment and is expected to be completed by August 28, 2027. Data analysis will begin in September 2027, with results anticipated in the first quarter of 2028. Conclusions: This study protocol outlines a randomized clinical trial designed to assess clinical outcomes associated with intercostal cryoanalgesia compared with thoracic epidural analgesia following thoracic surgery. The findings are expected to contribute to the evidence base on postoperative pain management and inform the design of future comparative and implementation studies in this field.

  • Open Access

    Intercostal cryoanalgesia versus thoracic epidural analgesia for postoperative pain control after thoracic surgery: study protocol for a randomized clinical trial (Preprint)

    by André Miotto, Juliana P. Franceschini, Maria Luiza de Paula Pereira, Isabella Correia da Rocha, Maria Luiza Campos Ferreira, Suéllen Battaglini Rolando, Ernesto Evangelista Neto, João Aléssio Juliano Perfeito

    BACKGROUND Post thoracotomy pain remains a major clinical challenge, with substantial impact on pulmonary function, postoperative recovery, and patient quality of life. Thoracic epidural analgesia is widely regarded as the standard of care; however, it is associated with potential complications, including hypotension, urinary retention, and inadequate analgesia in a subset of patients. Intercostal cryoanalgesia, a peripheral nerve block technique that induces temporary axonal degeneration through controlled freezing, has emerged as a potential alternative for prolonged postoperative pain control. OBJECTIVE The primary objective of this study is to compare postoperative hospital length of stay between intercostal cryoanalgesia and thoracic epidural analgesia. Secondary objectives include the evaluation of postoperative pain intensity, opioid consumption, adverse effects, postoperative complications, quality of life, quality of recovery, and patient satisfaction. METHODS This is a single-center, prospective, randomized, parallel-group clinical trial comparing intercostal cryoanalgesia with thoracic epidural analgesia for postoperative pain control in patients undergoing thoracic surgery. Fifty adult patients (≥18 years) are randomized 1:1 to either epidural or cryoanalgesia groups. All perioperative and postoperative care is provided by the attending clinical teams according to routine institutional practice, with no influence from the research team beyond randomized allocation. The primary endpoint is postoperative hospital length of stay. Secondary outcomes include pain intensity (visual analogue scale), opioid consumption, incidence of adverse effects and complications, quality of life (WHOQOL-BREF), and quality of recovery (QoR-15). Data are collected up to 1 year postoperatively. RESULTS Approval from the Human Research Ethics Committee was obtained in November 2024, and participant recruitment began in July 2025. Data collection commenced in September 2026 and is expected to be completed by August 28, 2027. Data analysis will begin in September 2027, with results anticipated in the first quarter of 2028. CONCLUSIONS This study protocol outlines a randomized clinical trial designed to assess clinical outcomes associated with intercostal cryoanalgesia compared with thoracic epidural analgesia following thoracic surgery. The findings are expected to contribute to the evidence base on postoperative pain management and inform the design of future comparative and implementation studies in this field. CLINICALTRIAL Brazilian Registry of Clinical Trials (ReBEC): identifier RBR-78zfpxd.

  • Open Access

    Estenose traqueal pós intubação: análise de 250 casos operados e o legado do professor Vicente Forte

    by Vicente Forte, Andre Miotto, Rodrigo Caetano DE Souza, Mario Claudio Ghefter, Petrucio Abrantes Sarmento, Maria Alenita DE Oliveira, Jaquelina Sonoe Ota Arakak, Joao Alessio Perfeito

  • Open Access

    Aplicação de inteligência artificial como suporte pós-operatório para pacientes submetidos à cirurgia torácica

    by Beatriz D’áVila Pereira DA Silva, Ernesto Evangelista Neto, João Aléssio Juliano Perfeito, André Miotto

    RESUMO Introdução: A inteligência artificial (IA) tem desempenhado um papel cada vez mais significativo na medicina, desde o diagnóstico por imagens até tratamentos personalizados. No pós-operatório, essa ferramenta pode otimizar o suporte ao paciente, esclarecendo dúvidas e reduzindo a necessidade de consultas presenciais. No entanto, sua confiabilidade e impacto na jornada do paciente ainda são pouco explorados. Esse estudo explorou o potencial da IA como artifício complementar ao cuidado de pacientes submetidos a cirurgia torácica, analisando a precisão das respostas, aceitação pelos pacientes e potencial para transformar o acompanhamento médico. Métodos: Foram coletadas dúvidas reais de pacientes, que foram respondidas tanto pelo chatGPT quanto por médicos especialistas. As respostas foram comparadas quanto à clareza, acurácia e completude. Os participantes avaliaram a satisfação com as informações fornecidas, a necessidade de buscar mais detalhes e o conforto em utilizar a IA sem supervisão médica. Resultados: Dos pacientes avaliados, 74,3% relataram que suas dúvidas foram completamente solucionadas pelo chatGPT, enquanto 91,4% consideraram a linguagem clara e acessível. No entanto, 62,8% ainda expressaram a necessidade de confirmação médica. Além disso, 51,4% dos participantes afirmaram que buscariam informações adicionais mesmo após a resposta da IA. Conclusão: Os resultados apontam que a IA tem grande potencial para melhorar a experiência pós-operatória dos pacientes, oferecendo respostas rápidas e acessíveis. No entanto, sua aplicação deve ser integrada a um modelo híbrido de assistência, combinando tecnologia com individualização médica.

  • Open Access

    Post-Intubation Tracheal Stenosis: Analysis of 250 Operated Cases and the Legacy of Professor Vicente Forte

    by Vicente Forte, Andre Miotto, Rodrigo Caetano DE Souza, Mario Claudio Ghefter, Petrucio Abrantes Sarmento, Maria Alenita DE Oliveira, Jaquelina Sonoe Ota Arakak, Joao Alessio Perfeito

  • Open Access

    Application of artificial intelligence as postoperative support for patients undergoing thoracic surgery

    by Beatriz D’áVila Pereira DA Silva, Ernesto Evangelista Neto, João Aléssio Juliano Perfeito, André Miotto

    Introduction: Artificial intelligence (AI) is playing an increasingly significant role in medicine, from imaging-based diagnosis to personalized treatment. In the postoperative period, it may enhance patient support by answering questions more clearly and reducing the need for in-person visits. However, its reliability and effects on the patient experience remain insufficiently studied. This study examined the potential of AI as a complementary tool in the care of patients undergoing thoracic surgery, assessing response accuracy, patient acceptance, and its potential to reshape postoperative follow-up.

  • Open Access

    Case Report: Cryoanalgesia for intractable thoracic pain due to chest wall tumor

    by Thays Sellan Paim, Myrna Guernelli, Rafael Soares Simoneti, André Miotto

    Introduction: Postoperative pain in thoracic surgery is a major concern, often delaying recovery. Cryoanalgesia, using pressurized nitrous oxide, offers long-term pain relief by temporarily blocking peripheral nerve function. It takes effect within 72 hours, so an intercostal nerve block is used for immediate pain relief. Cryoanalgesia is effective for severe pain, with minimal side effects and no drug interactions.Case report: A 63-year-old man with severe thoracic pain, unresponsive to opioids, was diagnosed with a typical carcinoid tumor after a CT scan revealed lesions in his lung, thoracic wall, and adrenal gland. He underwent surgery for the thoracic lesions with cryoanalgesia, leading to excellent recovery and no pain. A month later, the adrenal lesion was removed laparoscopically. He remains pain-free and free of recurrence after one year, indicating successful treatment.Conclusion: Cryoanalgesia provides long-term relief for chest pain caused by tumors, with minimal side effects. It improves recovery and should be considered an essential part of pain management in thoracic surgery.

  • Open Access

    Avaliação do Intervalo Entre o Diagnóstico e o Tratamento Definitivo do Câncer de Pulmão em uma Instituição Pública em São Paulo

    by Otavio Rocha Fiuza, Barbara Siqueira Souto Maior, Luísa Beisman DE Moraes, Daniel Augusto Xavier Carvalho, João Aléssio Juliano Perfeito, Ernesto Evangelista Neto, André Miotto

    RESUMO Objetivo: Este estudo teve como objetivo investigar o intervalo entre o diagnóstico e o tratamento cirúrgico definitivo de pacientes com câncer de pulmão em uma instituição pública em São Paulo. Método: Foi conduzido um estudo observacional retrospectivo, utilizando registros médicos para coletar dados sobre os períodos entre a primeira tomografia computadorizada de tórax alterada, a consulta inicial com o médico especialista e a ressecção tumoral subsequente. Resultados: A análise de 20 pacientes revelou um período de espera médio de 425,6 dias entre o diagnóstico e o tratamento definitivo. Neste intervalo, uma média de 282 dias transcorreu entre o diagnóstico e a consulta inicial com o especialista, enquanto o período entre a primeira consulta e o tratamento teve uma média de 143 dias. Ao comparar os estadiamentos inicial e final, 70% dos pacientes progrediram de estágio ao longo desse período. Conclusões: O intervalo identificado é alarmante e expõe os pacientes a riscos elevados durante este período de espera. Essa duração prolongada representa potenciais ameaças à saúde dos pacientes, resultando em comprometimento da qualidade de vida, aumento do risco de progressão da doença, redução das chances de cura e diminuição das perspectivas gerais de sobrevida. Abordar e minimizar este intervalo prolongado é crucial para melhorar os resultados dos pacientes e aumentar a eficácia do tratamento do câncer de pulmão.

  • Open Access

    Assessment of the interval between diagnosis and definitive treatment of lung cancer at a public institution in São Paulo

    by Otavio Rocha Fiuza, Barbara Siqueira Souto Maior, Luísa Beisman DE Moraes, Daniel Augusto Xavier Carvalho, João Aléssio Juliano Perfeito, Ernesto Evangelista Neto, André Miotto

    Introduction: This study aimed to investigate the interval between the diagnosis and definitive surgical treatment of lung cancer patients at a public institution in São Paulo. Method: A retrospective observational study was conducted, using medical records to collect data on the periods between the first abnormal chest computed tomography (CT) scan, the initial consultation with the specialist, and the subsequent tumor resection. Results: The analysis of 20 patients revealed a substantial average waiting period of 425.6 days between diagnosis and definitive treatment. During this interval, an average of 282 days elapsed between diagnosis and the initial specialist consultation, while the period between the first consultation and treatment averaged 143 days. By comparing the initial and final staging, 70% of the patients progressed to a higher stage over this period. Conclusions: The identified interval is concerning and exposes patients to elevated risks during this waiting period. This prolonged duration poses potential threats to patient health, resulting in decreased quality of life, increased risk of disease progression, reduced chances of cure, and diminished overall survival prospects. Addressing and minimizing this extended interval is crucial for improving patient outcomes and enhancing the effectiveness of lung cancer treatment.

  • Open Access

    A evolução do tabagismo - do convencional ao eletrônico

    by Lívia Akemi Ramos Takahashi, Otávio Rocha Fiuza, Vitória Cristina de Almeida, Renato Santos de Oliveira Filho, André Miotto, Elaine Kawano Horibe

    A história do tabagismo passa por uma transformação de percepção ao longo dos tempos. Inicialmente associado a práticas rituais e medicinais, o cigarro moderno ganhou popularidade no século XIX, sendo promovido como símbolo de status. Para a construção desta imagem gloriosa associada ao hábito de fumar, a mídia teve um importante papel através de propagandas da indústria do tabaco e, também, demonstrou resistência à publicação de matérias contra o fumo à medida que os estudos surgiam. No entanto, evidências científicas crescentes ligaram o tabagismo a sérios problemas de saúde no século XX, levando a uma mudança na percepção pública, de herói a vilão. Paralelamente, surgiram os cigarros eletrônicos como alternativa, visando substituir o tabaco queimado por um vapor aromatizado, reduzindo os efeitos relacionados à queima. Porém, o seu impacto na saúde ainda é objeto de debate, visto que recentemente foi possível associar pneumopatias como a EVALI ao uso do novo dispositivo de fumo. Sendo assim, a construção da linha do tempo nos ensina que a luta contra o tabagismo é contínua e requer uma abordagem multifacetada, que inclui ações de conscientização, regulação da indústria do tabaco e investimentos em pesquisa para entender melhor os impactos do tabagismo e de suas novas formas de consumo. A proteção da saúde pública deve permanecer como uma prioridade, e é essencial que autoridades de saúde em todo o mundo trabalhem em conjunto para enfrentar esse desafio global. Somente assim poderemos garantir um futuro mais saudável para as gerações futuras, livre dos danos causados pelo tabagismo.